January 23, 2015 — Takeda Pharmaceutical Co. has been hit with a lawsuit by the family of a man who died from bladder cancer after taking Actos for four years.
The lawsuit was filed on behalf of Moshe Bitton, a man from Henderson, Nevada. He was diagnosed with bladder cancer in August 2011 and died from the disease in October 2013.
The lawsuit was filed in federal court in Nevada on Tuesday, according to the Las Vegas Review-Journal.
Takeda is accused of concealing information linking Actos and bladder cancer. The Japanese pharmaceutical company is now facing about 3,972 similar lawsuits in a consolidated federal litigation in Louisiana, where fewer than 200 cases have been resolved.
Last year, Takeda was hit with a $9 billion jury verdict involving bladder cancer from Actos, though it was slashed down to $37 million under state laws capping punitive damages in October. That same month, Takeda lost a trial in Pennsylvania when a jury awarded $2 million to a woman who was diagnosed with bladder cancer after taking Actos.
In June 2014, Takeda won a trial involving two women with bladder cancer. That case went to trial in Las Vegas, Nevada.
The FDA warned in June 2011 that the risk of bladder cancer increased with higher doses and longer treatment with Actos. Their warnings were based on a five-year safety study that found a 40% increased risk of bladder cancer in patients who used high-dose Actos for one year.
Do I have an Actos Lawsuit?
The Schmidt Firm, PLLC is currently accepting Actos induced injury cases in all 50 states. If you or somebody you know has been diagnosed with bladder cancer, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.